References
Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P et al (2016) Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients. Transfusion 56:1828–1833
Boonyasampant M, Weitz IC, Kay B, Boonchalermvichian C, Liebman HA, Shulman IA (2015) Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion 55:2398–2403
Irani MS, Richards C (2011) Hemolytic transfusion reaction due to anti-IH. Transfusion 51:2676–2678
Darabi K, Makar RS (2008) Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Transfusion 48:964–968
Campbell SA, Shirey RS, King KE, Ness PM (2000) An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease. Transfusion 40:828–831
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
There is no conflict of interest to declare.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Shao, LN., Song, WQ., Wang, N. et al. Incidental Discovery of Anti-IH in a Patient Planned for Caesarean Section and it’s Repercussions. Indian J Hematol Blood Transfus 34, 368–369 (2018). https://doi.org/10.1007/s12288-017-0891-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-017-0891-z